ABOUT THIS EPISODE

English

SEARCH PAST EPISODES

Search past episodes of Dishing The Science with Dr. Sue.

OTHER EPISODES IN THIS PODCAST

Obesity expert groups around the world have created guidance documents to reframe the diagnosis and assessment of obesity, to look beyond BMI, and embracing weight-related health issues, which differ in their approaches. Today I'm talking about how we can distill these down into one very simpl…
While we now have several injectable GLP-1s based treatments for weight management around the world [liraglutide (Saxenda), semaglutide (Wegovy), tirzepatide (Zepbound/Mounjaro)], there are no GLP-1s currently available in a pill format for obesity treatment. But that is likely soon to change, back…
Two out of three people with type 2 diabetes have 'fatty liver disease' (now called MASH/MASLD).  Should everyone with prediabetes or type 2 diabetes be screened? Find out what the brand new Diabetes Canada Guidelines say here! Learn more: https://drsue.ca/2025/09/does-everyone-with-type-…
Can GLP-1 medications cause altered skin sensations? Find out what we know here. Learn more: https://drsue.ca/2025/10/can-glp-1-medications-cause-funky-skin-sensations-dysesthesia/ Any medical discussion on this podcast is intended to be of a general nature only, and is intended for a Canadian audi…
Disclaimer: The podcast and artwork embedded on this page are from Dr. Sue Pedersen, which is the property of its owner and not affiliated with or endorsed by Listen Notes, Inc.